PyInvesting

Market research

HIKAL.NSE Hikal Limited

NSE INR Healthcare

Latest close

220.76 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
28B
P/E ratio
Not available
Analyst target
300
Dividend yield
0.0%
Beta
0.53

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Hikal Limited is currently in a long term uptrend where the price is trading 125.8% above its 200 day moving average.

From a valuation standpoint, the stock is 72.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.

Hikal Limited's total revenue rose by 14.7% to $5B since the same quarter in the previous year.

Its net income has increased by 42.0% to $403M since the same quarter in the previous year.

Finally, its free cash flow fell by 45.2% to $660M since the same quarter in the previous year.

Based on the above factors, Hikal Limited gets an overall score of 4/5.